These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6110201)

  • 1. [The effect of Tobanum on human cardioelectrophysiology].
    Borbola J; Elkefarna A; Török E
    Orv Hetil; 1980 Aug; 121(35):2129-32. PubMed ID: 6110201
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of Tobanum on the electrophysiology of the heart].
    Tarján J; Rostás L; Wagner G; Józan M; Lascsik L
    Orv Hetil; 1981 Dec; 122(49):3005-8. PubMed ID: 6120494
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of beta receptor blockaders on the atrioventricular stimulus conduction. Study by means of bundle of His electrocardiography].
    Halter J; Pfisterer M; Nager F
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1554-7. PubMed ID: 4153699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of antiarrhythmic drugs].
    Lastra Santos LA; Jiménez JR
    An R Acad Nac Med (Madr); 1975; 92(1):36-105. PubMed ID: 236678
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
    Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retardation of the excitation conduction by propaphenone. Duration and dosage effect relation after oral administration (author's transl)].
    Beck OA; Abdulla S; Hochrein H
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1369-72. PubMed ID: 809677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of tobanum in arrhythmias.
    Hankóczy J; Török E; Békés M; Podmaniczky M; Cheh K
    Ther Hung; 1984; 32(1):16-8. PubMed ID: 6085943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of electrophysiological effects of betaxolol].
    Ponsonnaille J; Citron B; Trolese JF; Serignat B; Gras H
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):149-53. PubMed ID: 2882723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The secondary poststimulative phase after rapid atrial pacing: its importance in the diagnosis of sinus node dysfunction.
    Szatmáry L; Veress G; Borbola J; Elkafarna A; Zorándy A; Czapko M
    Acta Med Acad Sci Hung; 1981; 38(2):97-107. PubMed ID: 6119867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esmolol--a short-acting i.v. beta-blocker.
    Med Lett Drugs Ther; 1987 Jun; 29(742):57-8. PubMed ID: 2884558
    [No Abstract]   [Full Text] [Related]  

  • 13. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of trimepranol and propranolol in thyreotoxicosis and in patients with arrhythmia].
    Vána S; Felt V; Nĕmec J; Zamrazil V
    Cas Lek Cesk; 1972 Jun; 111(20):454-9. PubMed ID: 4402995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological treatment of arrhythmia].
    Kuch J
    Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of the non-specific cardiodepressant effects of beta-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis.
    Hellenbrecht D; Grobecker H; Müller KF
    Eur J Pharmacol; 1974 Dec; 29(2):223-5. PubMed ID: 4155366
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atropine in the diagnosis and treatment of arrhythmia].
    Kolber-Postepska B
    Wiad Lek; 1984 Sep; 37(16):1257-62. PubMed ID: 6393596
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrocardiogram of patients with pheochromocytoma with special reference to the effect of beta blockaders].
    Dabrowska B
    Kardiol Pol; 1980; 23(11):961-9. PubMed ID: 6109785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.